跳至主要内容
临床试验/CTRI/2017/07/009033
CTRI/2017/07/009033招募中3 期

Vitamin D as an adjunct in the treatment of systemic lupus erythematosus-a double blind randomized control trial.

Bidyut Kumar Das0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Patients fulfilling the SLICC criteria for SLE.
  • 2)Baseline 25(OH)D concentration <20ng/ml.
  • 3)Stable disease at screening , defined by SLEDAI score of <4.
  • 4)If on corticosteroids, the dose must be <20mg/day(Prednisone) and must be stable for preceding 4 weeks prior to entry into the study.
  • 5)If on other immunomodulators like azathioprine,mycophenolate,leflunomide, hydroxycholoroquine and methotrexate dose must be stable for 3 months prior to screening and at study entry.
  • 6)Patients giving informed consent for participating in the trial.

排除标准

  • 1)Pregnancy
  • 2)Overlap syndrome.
  • 3)SLE with renal failure or on dialysis.
  • 4)Hypercalcemia
  • 5)Hyperparathyroidism
  • 6)History of Renal calculi
  • 7)Patients with active tuberculosis
  • 8)Patients with viral infections like HIV, HBV, HCV.
  • 9)Patients with sepsis
  • 10)Baseline 25(OH)D concentration >40ng/ml.
  • 11)Not willing to give informed consent

研究者

发起方
Bidyut Kumar Das

相似试验